Jackson Square Partners LLC Sells 11,409 Shares of CME Group Inc. $CME

Jackson Square Partners LLC cut its stake in shares of CME Group Inc. (NASDAQ:CME) by 35.2% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 20,978 shares of the financial services provider’s stock after selling 11,409 shares during the quarter. CME Group accounts for about 2.1% of Jackson Square Partners LLC’s portfolio, making the stock its 11th largest position. Jackson Square Partners LLC’s holdings in CME Group were worth $5,782,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also added to or reduced their stakes in the stock. Webster Bank N. A. grew its stake in shares of CME Group by 206.9% during the second quarter. Webster Bank N. A. now owns 89 shares of the financial services provider’s stock worth $25,000 after buying an additional 60 shares during the last quarter. Cornerstone Planning Group LLC lifted its stake in shares of CME Group by 122.2% in the 1st quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider’s stock valued at $26,000 after acquiring an additional 55 shares during the last quarter. Highline Wealth Partners LLC boosted its holdings in shares of CME Group by 84.3% during the 2nd quarter. Highline Wealth Partners LLC now owns 94 shares of the financial services provider’s stock valued at $26,000 after acquiring an additional 43 shares in the last quarter. Ransom Advisory Ltd acquired a new stake in shares of CME Group during the 1st quarter valued at $31,000. Finally, Trifecta Capital Advisors LLC grew its position in CME Group by 59.2% during the 2nd quarter. Trifecta Capital Advisors LLC now owns 113 shares of the financial services provider’s stock worth $31,000 after acquiring an additional 42 shares during the last quarter. 87.75% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In related news, insider Sunil Cutinho sold 11,896 shares of the stock in a transaction on Tuesday, August 26th. The shares were sold at an average price of $271.47, for a total transaction of $3,229,407.12. Following the transaction, the insider directly owned 17,440 shares of the company’s stock, valued at $4,734,436.80. This represents a 40.55% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director William R. Shepard purchased 262 shares of CME Group stock in a transaction on Thursday, September 25th. The stock was bought at an average price of $265.19 per share, with a total value of $69,479.78. Following the completion of the acquisition, the director directly owned 258,459 shares of the company’s stock, valued at approximately $68,540,742.21. This trade represents a 0.10% increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. In the last three months, insiders sold 14,043 shares of company stock worth $3,791,486. Company insiders own 0.30% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms have commented on CME. Deutsche Bank Aktiengesellschaft upgraded CME Group from a “hold” rating to a “buy” rating and increased their target price for the company from $266.00 to $300.00 in a research report on Thursday, October 23rd. Barclays lowered their price objective on CME Group from $298.00 to $280.00 and set an “equal weight” rating for the company in a research note on Wednesday, October 8th. Jefferies Financial Group cut their target price on shares of CME Group from $313.00 to $304.00 and set a “buy” rating on the stock in a research report on Friday, October 10th. Rothschild & Co Redburn boosted their target price on shares of CME Group from $297.00 to $300.00 and gave the stock a “neutral” rating in a report on Thursday. Finally, The Goldman Sachs Group upped their price target on shares of CME Group from $262.00 to $263.00 and gave the company a “sell” rating in a research report on Thursday, October 23rd. Eight investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and three have assigned a Sell rating to the stock. According to MarketBeat, CME Group has a consensus rating of “Hold” and a consensus target price of $286.06.

CME Group Price Performance

CME stock opened at $276.50 on Friday. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.12. The firm has a market cap of $99.71 billion, a price-to-earnings ratio of 26.79, a PEG ratio of 4.41 and a beta of 0.38. The company’s fifty day simple moving average is $265.86 and its 200 day simple moving average is $272.29. CME Group Inc. has a 12-month low of $222.56 and a 12-month high of $290.79.

CME Group (NASDAQ:CME) last issued its quarterly earnings results on Wednesday, October 22nd. The financial services provider reported $2.68 earnings per share for the quarter, topping analysts’ consensus estimates of $2.63 by $0.05. CME Group had a return on equity of 14.61% and a net margin of 58.84%.The firm had revenue of $1.54 billion during the quarter, compared to the consensus estimate of $1.56 billion. During the same period last year, the business posted $2.68 EPS. The business’s revenue was down 3.0% compared to the same quarter last year. On average, analysts expect that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 30th. Shareholders of record on Friday, December 12th will be paid a $1.25 dividend. The ex-dividend date of this dividend is Friday, December 12th. This represents a $5.00 annualized dividend and a yield of 1.8%. CME Group’s payout ratio is 48.45%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.